Huge clear cell carcinoma of the cervix in teenager not associated with diethylstilbestrol: A brief case report [2]

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 117, Issue 1, 2004, Pages 115-116

  Ding, Dah Ching ^a   Chang, Fun Wei ^b   Yu, Mu Hsien ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; ANAMNESIS; BRACHYTHERAPY; CANCER SIZE; CANCER STAGING; CASE REPORT; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CYTOPATHOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; MEDICAL EXAMINATION; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIODIAGNOSIS; UTERINE CERVIX CARCINOMA;

EID: 5044238715     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.02.027     Document Type: Letter

References (10)

1. Kaminski P.F., Maier R.C. Clear cell adenomcarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet. Gynecol. 62:1983;720-727
2. Trimble E.L., Rubinstein L.V., Menck H.R., Hankey B.F., Kosary C., Giusti R.M. Vaginal clear cell adenocarcinoma in the United States. Gynecol. Oncol. 61:1996;113-115
3. Melnick S., Cole P., Anderson D., Herbst A. Rates and risks of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix: an update. N. Engl. J. Med. 316:1987;514-516
4. Herbst A.L., Cole P., Norusis M.J., Welch W.R., Scully R.E. Epidemiologic adenocarcinoma of the vagina and cervix. Am. J. Obstet. Gynecol. 135:1979;876-886
5. Herbst A.L., Anderson S., Hubby M.M., Haenszel W.M., Kaufman R.H., Noller K.L. Risk factors for the development of diethylstilbestrol - associated clear cell adenocarcinoma: a case-control study. Am. J. Obstet. Gyncol. 154:1986;814-822
6. Boyd J., Takahashi H., Waggoner S.E., Jones L.A., Hajek R.A., Wharton J.T., et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer. 77:1996;507-513
7. Waggoner S.E., Anderson S.M., Luce M.C., Takahashi H., Boyd J. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol. Oncol. 60:1996;339-344
8. Jones W.B., Tan L.K., Lewis J.L. Jr. Late recurrence of clear cell adenocarinoma of the vagina and cervix: a report of three cases. Gynecol. Oncol. 51:1993;266-271
9. Reich O., Tamussino K., Lahousen M., Pickel H., Haas J., Winter R. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol. Oncol. 76:2000;331-335
10. Stehman F.B., Rose P.G., Greer B.E., Roy M., Plante M., Penalver M., et al. Innovations in the treatment of invasive cervical cancer. Cancer. 98(Suppl. 9):2003;2052-2063